Pharmaceutical News

RSS

Agile Therapeutics to report on new generation of transdermal contraceptives

Dr. Thomas M. Rossi, President and Chief Executive Officer of Agile Therapeutics, Inc., will report on the company's progress in developing a new generation of transdermal contraceptives at the BIO 2007 annual international conference on biotechnology.

24 Apr 2007

Abbott continues drug blacklist in Thailand, says AIDS Healthcare Foundation

AIDS Healthcare Foundation has chastised Abbott Laboratories for its 'quid pro quo' offer to the Government of Thailand to lower its price for Abbott's key AIDS drug, Aluvia (a heat-stable tablet version of Kaletra) to approximately USD$800 per patient per year -- an offer contingent upon Abbott's demand that Thailand immediately halt issuing compulsory licenses for the generic manufacture of this lifesaving drug.

24 Apr 2007

Thailand wins round two in battle to access cheaper AIDS drugs

The military government in Thailand has won the second round in it's battle to access cheaper AIDS drugs for the nations 580,000 AIDS sufferers.

23 Apr 2007

New drug Maraviroc an alternative in the fight against HIV

An experimental AIDS drug appears to offer an alternative drug in the fight against HIV.

22 Apr 2007

ZARS announces Swedish marketing approval for Rapydan

ZARS, Inc. has announced that the Medical Products Agency in Sweden has approved Rapydan 70 mg/70 mg medicated plaster, a topical local anesthetic patch.

20 Apr 2007

Schering-Plough announces ZETIA spproved in Japan

Schering-Plough Corporation has announced that Schering-Plough K.K., the company's country operation in Japan, has received marketing approval for ZETIA (ezetimibe), a novel cholesterol-lowering agent that inhibits the absorption of cholesterol in the intestine.

20 Apr 2007

Generics are increasing competition and lower prescription drug prices

According to a new study by researchers at the Massachusetts Institute of Technology's (MIT) School of Management and Analysis Group Inc., there is no evidence that the recent increase in prevalence of authorized generics has resulted in delays in generic entry into the marketplace.

20 Apr 2007

Indevus Pharmaceuticals submits supplemental NDA for VALSTAR

Indevus Pharmaceuticals has announced that it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval to reintroduce VALSTAR in the United States.

20 Apr 2007

FDA confirms Mylan's status as only approved ANDA for all strengths of Amlodipine Besylate tablets

Mylan Laboratories has announced that the U.S. Food and Drug Administration (FDA) has confirmed Mylan's current status as the only approved ANDA for all strengths of Amlodipine Besylate Tablets.

20 Apr 2007

Should government negotiate drug prices?

The following is written by Dr. Gary A. Puckrein, PhD, President and Chief Executive Officer of National Minority Quality Forum, on the topic of drug prices and the emerging majority:

20 Apr 2007

Bill broadening prescribing rights to psychologists unsafe

Setting the stage for another legislative battle that puts mental health patients in the middle, a bill seeking to give licensed psychologists prescribing privileges for dangerous medications is scheduled to be heard on April 23, 2007 in the Senate Business, Professions and Economic Development Committee.

20 Apr 2007

AstraZeneca addresses lack of ethnically diverse patients in clinical trials

To address the lack of ethnically diverse patients in clinical trials across the U.S., AstraZeneca has announced, in collaboration with the National Medical Association (NMA) and the Interamerican College of Physicians and Surgeons (ICPS), new efforts to increase ethnically diverse physician investigator participation in clinical trials.

20 Apr 2007

Alpharma moves into China with Tongde Pharmaceutical acquisition

Alpharma Inc. has announced it has acquired the assets of Shenzhou Tongde Pharmaceutical Co. Ltd ("Tongde") in Shenzhou City, China.

20 Apr 2007

Access Pharmaceuticals and Somanta Pharmaceuticals sign merger agreement

Access Pharmaceuticals and Somanta Pharmaceuticals have announced that they have signed a definitive merger agreement by which Access will acquire Somanta.

20 Apr 2007

Vasogen and Grupo Ferrer to commercialize Celacade in Europe

Vasogen has announced a collaboration with Grupo Ferrer Internacional, S.A. ("Ferrer"), to commercialize Vasogen's Celacade technology for the treatment of chronic heart failure in the European Union and in certain Latin American countries.

19 Apr 2007

Viragen announces European Multiferon licensing agreement

Viragen and its majority-owned subsidiary, Viragen International have announced that a licensing agreement has been completed with Swedish Orphan International AB, granting exclusive marketing rights to Multiferon (multi-subtype, human alpha interferon) for the European Union (excluding previously licensed member states).

19 Apr 2007

Lexicon-Genentech reveals potential therapeutic targets

Lexicon Genetics Incorporated has announced that data was presented highlighting potential therapeutic targets related to its collaboration with Genentech, Inc. at the Society for Biomolecular Sciences 13th Annual Conference & Exhibition in Montreal, Canada.

19 Apr 2007

Modafinil which improves intelligence under scrutiny by Health Department

The British government is examining the impact of a new generation of drugs that are claimed to make people more intelligent.

19 Apr 2007

FDA approves new Actonel dose

The U.S. Food and Drug Administration (FDA) approved a new dose for Actonel (risedronate sodium tablets) that will give patients the option of taking one Actonel 75 mg tablet on two consecutive days, for a total of two tablets monthly, to treat and prevent their postmenopausal osteoporosis.

18 Apr 2007

Schering-Plough selects Pharmacopeia compund for development

Pharmacopeia has announced that a compound identified through the Company's collaboration with Schering-Plough has been selected by Schering- Plough for preclinical development.

18 Apr 2007